ペプチド治療薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Peptide Therapeutics Market Insights and Forecast to 2028

• レポートコード：QY2203B05999
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のペプチド治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペプチド治療薬の世界市場のxxx％を占める「注射」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のペプチド治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのペプチド治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペプチド治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ペプチド治療薬のグローバル主要メーカーには、Sanofi、Teva、Novo Nordisk、Takeda、Eli Lilly、AstraZeneca、Novartis、AbbVie、Ipsen、Ferring、Merck、The Medicines、J & Jなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ペプチド治療薬市場は、種類と用途によって区分されます。世界のペプチド治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
注射、経口、その他

【用途別セグメント】
がん、代謝性疾患、中枢神経系、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ペプチド治療薬製品概要
- 種類別市場（注射、経口、その他）
- 用途別市場（がん、代謝性疾患、中枢神経系、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のペプチド治療薬販売量予測2017-2028
- 世界のペプチド治療薬売上予測2017-2028
- ペプチド治療薬の地域別販売量
- ペプチド治療薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ペプチド治療薬販売量
- 主要メーカー別ペプチド治療薬売上
- 主要メーカー別ペプチド治療薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（注射、経口、その他）
- ペプチド治療薬の種類別販売量
- ペプチド治療薬の種類別売上
- ペプチド治療薬の種類別価格
・用途別市場規模（がん、代謝性疾患、中枢神経系、その他）
- ペプチド治療薬の用途別販売量
- ペプチド治療薬の用途別売上
- ペプチド治療薬の用途別価格
・北米市場
- 北米のペプチド治療薬市場規模（種類別、用途別）
- 主要国別のペプチド治療薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのペプチド治療薬市場規模（種類別、用途別）
- 主要国別のペプチド治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のペプチド治療薬市場規模（種類別、用途別）
- 主要国別のペプチド治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のペプチド治療薬市場規模（種類別、用途別）
- 主要国別のペプチド治療薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのペプチド治療薬市場規模（種類別、用途別）
- 主要国別のペプチド治療薬市場規模（トルコ、サウジアラビア）
・企業情報
Sanofi、Teva、Novo Nordisk、Takeda、Eli Lilly、AstraZeneca、Novartis、AbbVie、Ipsen、Ferring、Merck、The Medicines、J & J
・産業チェーン及び販売チャネル分析
- ペプチド治療薬の産業チェーン分析
- ペプチド治療薬の原材料
- ペプチド治療薬の生産プロセス
- ペプチド治療薬の販売及びマーケティング
- ペプチド治療薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ペプチド治療薬の産業動向
- ペプチド治療薬のマーケットドライバー
- ペプチド治療薬の課題
- ペプチド治療薬の阻害要因
・主な調査結果

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Market Analysis and Insights: Global Peptide Therapeutics Market
The global Peptide Therapeutics market size is projected to reach US$ 63600 million by 2028, from US$ 34550 million in 2021, at a CAGR of 9.0% during 2022-2028.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide Therapeutics market.
Global Peptide Therapeutics Scope and Market Size
Peptide Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Peptide Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Injection
Oral
Other
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Market Perspective (2017-2028)
2.2 Peptide Therapeutics Growth Trends by Region
2.2.1 Peptide Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peptide Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Peptide Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Peptide Therapeutics Market Dynamics
2.3.1 Peptide Therapeutics Industry Trends
2.3.2 Peptide Therapeutics Market Drivers
2.3.3 Peptide Therapeutics Market Challenges
2.3.4 Peptide Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Therapeutics Players by Revenue
3.1.1 Global Top Peptide Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Therapeutics Revenue
3.4 Global Peptide Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Revenue in 2021
3.5 Peptide Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Therapeutics Breakdown Data by Type
4.1 Global Peptide Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Peptide Therapeutics Forecasted Market Size by Type (2023-2028)
5 Peptide Therapeutics Breakdown Data by Application
5.1 Global Peptide Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Peptide Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peptide Therapeutics Market Size (2017-2028)
6.2 North America Peptide Therapeutics Market Size by Type
6.2.1 North America Peptide Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Peptide Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Peptide Therapeutics Market Share by Type (2017-2028)
6.3 North America Peptide Therapeutics Market Size by Application
6.3.1 North America Peptide Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Peptide Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Peptide Therapeutics Market Share by Application (2017-2028)
6.4 North America Peptide Therapeutics Market Size by Country
6.4.1 North America Peptide Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Peptide Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Peptide Therapeutics Market Size (2017-2028)
7.2 Europe Peptide Therapeutics Market Size by Type
7.2.1 Europe Peptide Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Peptide Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Peptide Therapeutics Market Share by Type (2017-2028)
7.3 Europe Peptide Therapeutics Market Size by Application
7.3.1 Europe Peptide Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Peptide Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Peptide Therapeutics Market Share by Application (2017-2028)
7.4 Europe Peptide Therapeutics Market Size by Country
7.4.1 Europe Peptide Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Peptide Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Peptide Therapeutics Market Size by Type
8.2.1 Asia-Pacific Peptide Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Peptide Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Peptide Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Peptide Therapeutics Market Size by Application
8.3.1 Asia-Pacific Peptide Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Peptide Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Peptide Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Peptide Therapeutics Market Size by Region
8.4.1 Asia-Pacific Peptide Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Peptide Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide Therapeutics Market Size (2017-2028)
9.2 Latin America Peptide Therapeutics Market Size by Type
9.2.1 Latin America Peptide Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Peptide Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Peptide Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Peptide Therapeutics Market Size by Application
9.3.1 Latin America Peptide Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Peptide Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Peptide Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Peptide Therapeutics Market Size by Country
9.4.1 Latin America Peptide Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Peptide Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Peptide Therapeutics Market Size by Type
10.2.1 Middle East & Africa Peptide Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Peptide Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Peptide Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Peptide Therapeutics Market Size by Application
10.3.1 Middle East & Africa Peptide Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Peptide Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Peptide Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Peptide Therapeutics Market Size by Country
10.4.1 Middle East & Africa Peptide Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Peptide Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide Therapeutics Introduction
11.1.4 Sanofi Revenue in Peptide Therapeutics Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide Therapeutics Introduction
11.2.4 Teva Revenue in Peptide Therapeutics Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Business (2017-2022)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide Therapeutics Introduction
11.4.4 Takeda Revenue in Peptide Therapeutics Business (2017-2022)
11.4.5 Takeda Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Peptide Therapeutics Business (2017-2022)
11.5.5 Eli Lilly Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Peptide Therapeutics Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide Therapeutics Introduction
11.7.4 Novartis Revenue in Peptide Therapeutics Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide Therapeutics Introduction
11.8.4 AbbVie Revenue in Peptide Therapeutics Business (2017-2022)
11.8.5 AbbVie Recent Developments
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide Therapeutics Introduction
11.9.4 Ipsen Revenue in Peptide Therapeutics Business (2017-2022)
11.9.5 Ipsen Recent Developments
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide Therapeutics Introduction
11.10.4 Ferring Revenue in Peptide Therapeutics Business (2017-2022)
11.10.5 Ferring Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide Therapeutics Introduction
11.11.4 Merck Revenue in Peptide Therapeutics Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide Therapeutics Introduction
11.12.4 The Medicines Revenue in Peptide Therapeutics Business (2017-2022)
11.12.5 The Medicines Recent Developments
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Peptide Therapeutics Introduction
11.13.4 J & J Revenue in Peptide Therapeutics Business (2017-2022)
11.13.5 J & J Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Peptide Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Peptide Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Peptide Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Peptide Therapeutics Market Share by Region (2017-2022)
Table 9. Global Peptide Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Peptide Therapeutics Market Share by Region (2023-2028)
Table 11. Peptide Therapeutics Market Trends
Table 12. Peptide Therapeutics Market Drivers
Table 13. Peptide Therapeutics Market Challenges
Table 14. Peptide Therapeutics Market Restraints
Table 15. Global Peptide Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Peptide Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Peptide Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2021)
Table 18. Ranking of Global Top Peptide Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Therapeutics Product Solution and Service
Table 22. Date of Enter into Peptide Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Peptide Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Peptide Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Peptide Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Peptide Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Peptide Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Peptide Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Peptide Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Peptide Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Peptide Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Peptide Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Peptide Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Peptide Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Peptide Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Peptide Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Peptide Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Peptide Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Peptide Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Peptide Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Peptide Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Peptide Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Peptide Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Peptide Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Peptide Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Peptide Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Peptide Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Peptide Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Peptide Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Peptide Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Peptide Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Peptide Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Peptide Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Peptide Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Peptide Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Peptide Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Peptide Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Peptide Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Peptide Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Peptide Therapeutics Product
Table 65. Sanofi Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Sanofi Recent Developments
Table 67. Teva Company Details
Table 68. Teva Business Overview
Table 69. Teva Peptide Therapeutics Product
Table 70. Teva Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Teva Recent Developments
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Peptide Therapeutics Product
Table 75. Novo Nordisk Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Novo Nordisk Recent Developments
Table 77. Takeda Company Details
Table 78. Takeda Business Overview
Table 79. Takeda Peptide Therapeutics Product
Table 80. Takeda Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 81. Takeda Recent Developments
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Peptide Therapeutics Product
Table 85. Eli Lilly Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Eli Lilly Recent Developments
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Peptide Therapeutics Product
Table 90. AstraZeneca Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 91. AstraZeneca Recent Developments
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Peptide Therapeutics Product
Table 95. Novartis Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Novartis Recent Developments
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Peptide Therapeutics Product
Table 100. AbbVie Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 101. AbbVie Recent Developments
Table 102. Ipsen Company Details
Table 103. Ipsen Business Overview
Table 104. Ipsen Peptide Therapeutics Product
Table 105. Ipsen Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Ipsen Recent Developments
Table 107. Ferring Company Details
Table 108. Ferring Business Overview
Table 109. Ferring Peptide Therapeutics Product
Table 110. Ferring Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Ferring Recent Developments
Table 112. Merck Company Details
Table 113. Merck Business Overview
Table 114. Merck Peptide Therapeutics Product
Table 115. Merck Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 116. Merck Recent Developments
Table 117. The Medicines Company Details
Table 118. The Medicines Business Overview
Table 119. The Medicines Peptide Therapeutics Product
Table 120. The Medicines Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 121. The Medicines Recent Developments
Table 122. J & J Company Details
Table 123. J & J Business Overview
Table 124. J & J Peptide Therapeutics Product
Table 125. J & J Revenue in Peptide Therapeutics Business (2017-2022) & (US$ Million)
Table 126. J & J Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Injection Features
Figure 3. Oral Features
Figure 4. Other Features
Figure 5. Global Peptide Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Cancer Case Studies
Figure 7. Metabolic Disorders Case Studies
Figure 8. Central Nervous System Case Studies
Figure 9. Other Case Studies
Figure 10. Peptide Therapeutics Report Years Considered
Figure 11. Global Peptide Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Peptide Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Peptide Therapeutics Market Share by Region: 2021 VS 2028
Figure 14. Global Peptide Therapeutics Market Share by Players in 2021
Figure 15. Global Top Peptide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Peptide Therapeutics Revenue in 2021
Figure 17. North America Peptide Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Peptide Therapeutics Market Size Market Share by Type (2017-2028)
Figure 19. North America Peptide Therapeutics Market Size Market Share by Application (2017-2028)
Figure 20. North America Peptide Therapeutics Market Size Share by Country (2017-2028)
Figure 21. United States Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Peptide Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Peptide Therapeutics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Peptide Therapeutics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Peptide Therapeutics Market Size Share by Country (2017-2028)
Figure 27. Germany Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Peptide Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Peptide Therapeutics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Peptide Therapeutics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Peptide Therapeutics Market Size Share by Region (2017-2028)
Figure 37. China Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Peptide Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Peptide Therapeutics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Peptide Therapeutics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Peptide Therapeutics Market Size Share by Country (2017-2028)
Figure 47. Mexico Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Peptide Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Peptide Therapeutics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Peptide Therapeutics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Peptide Therapeutics Market Size Share by Country (2017-2028)
Figure 53. Turkey Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Peptide Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 57. Teva Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 58. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 59. Takeda Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 60. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 62. Novartis Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 63. AbbVie Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 64. Ipsen Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 65. Ferring Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 66. Merck Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 67. The Medicines Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 68. J & J Revenue Growth Rate in Peptide Therapeutics Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Global Metabotropic Glutamate Receptor 2 Market Insights and Forecast to 2028
QY2203B06583 2022年3月 88Pages
新型コロナウイルス感染症のパンデミックにより、世界のメタボトロピックグルタミン酸受容体2の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

神経障害性疼痛治療のグローバル市場インサイト・予測（～2028年）

Global Neuropathy Pain Treatment Market Insights and Forecast to 2028
QY2203B11217 2022年3月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界の神経障害性疼痛治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に神経障害性疼痛治療...

ヨウ素-125のグローバル市場インサイト・予測（～2028年）

Global Iodine-125 Market Insights and Forecast to 2028
QY2203B06788 2022年3月 74Pages
新型コロナウイルス感染症のパンデミックにより、世界のヨウ素-125の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヨウ素-125の世界市...

カスパーゼ8のグローバル市場インサイト・予測（～2028年）

Global Caspase 8 Market Insights and Forecast to 2028
QY2203B02252 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のカスパーゼ8の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカスパーゼ8の世界市場の...

グルタミルアミノペプチダーゼのグローバル市場インサイト・予測（～2028年）

Global Glutamyl Aminopeptidase Market Insights and Forecast to 2028
QY2203B02638 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のグルタミルアミノペプチダーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルタミ...

マイクロアルブミン測定器のグローバル市場インサイト・予測（～2028年）

Global Microalbumin Test Market Insights and Forecast to 2028
QY2203B06344 2022年3月 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のマイクロアルブミン測定器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にマイクロアル...

スマトリプタンオートインジェクターのグローバル市場インサイト・予測（～2028年）

Global Sumatriptan Autoinjector Market Insights and Forecast to 2028
QY2203B03663 2022年3月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界のスマトリプタンオートインジェクターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にス...

コロニーカウンターのグローバル市場インサイト・予測（～2028年）

Global Colony Counters Market Insights and Forecast to 2028
QY2203B02861 2022年3月 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のコロニーカウンターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコロニーカウンター...

LFAベース心臓のグローバル市場インサイト・予測（～2028年）

Global LFA-based Cardiac Market Insights and Forecast to 2028
QY2203B00773 2022年3月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界のLFAベース心臓の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にLFAベース心臓 ...

放射性医薬品溶液のグローバル市場インサイト・予測（～2028年）

Global Radiopharmaceutical Solutions Market Insights, Forecast to 2028
QY2203B13739 2022年3月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の放射性医薬品溶液の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に放射性医薬品溶液の世...

新エネルギー車（NEV）用制御システムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global New Energy Vehicle Control System Market The global New Energy Vehicle Control System market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Ve…
単結晶育成炉装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Monocrystal Growth Furnace Instrument Market Due to the COVID-19 pandemic, the global Monocrystal Growth Furnace Instrument market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % durin…
自動車用空気圧コンフォートシートシステムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Automotive Pneumatic Comfort Seat System Market The global Automotive Pneumatic Comfort Seat System market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this hea…
ペプチド合成のグローバル市場 2021年：企業別、地域別、種類・用途別 The Peptide Synthesis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
抗アレルギー薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Anti-allergic Drugs Market The global Anti-allergic Drugs market size is projected to reach US$ 14400 million by 2028, from US$ 10980 million in 2021, at a CAGR of 3.9% during 2022-2028. Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global…